83R4525 MCK-F
 
  By: Zerwas, Naishtat H.B. No. 838
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the monitoring of certain medications provided to
  foster children.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 266.001, Family Code, is amended by
  adding Subdivision (6) to read as follows:
               (6)  "Psychotropic drug" has the meaning assigned by
  Section 261.111.
         SECTION 2.  Chapter 266, Family Code, is amended by adding
  Section 266.011 to read as follows:
         Sec. 266.011.  MONITORING USE OF PSYCHOTROPIC DRUG. The
  person authorized to consent to medical treatment for a foster
  child prescribed a psychotropic drug shall ensure that the child
  has an office visit with the prescribing physician at least once
  every 90 days to allow the physician to:
               (1)  appropriately monitor the side effects of the
  drug; and
               (2)  determine whether:
                     (A)  the drug is helping the child achieve the
  physician's treatment goals; and
                     (B)  continued use of the drug is appropriate.
         SECTION 3.  The heading to Subchapter A, Chapter 266, Family
  Code, is repealed.
         SECTION 4.  This Act takes effect September 1, 2013.